February 8, 2012

Walmart isn’t about to let the grass grow under its feet in Canada.

January 31, 2012

In an effort to strengthen its focus on its corporate-owned Rexall and Rexall/Pharma Plus store network, Katz Group Canada has signed a definitive agreement to sell its banner pharmacy business, Drug Trading, and its franchise pharmacy business, Medicine Shoppe Canada, to McKesson for about CAD $920 million in cash.

January 27, 2012

Just a few weeks after unveiling the locations of its first 24 stores in Canada, Target released an expanded list of stores that will debut in 2013.

December 19, 2011

Drug maker Valeant Pharmaceuticals has launched a hostile takeover bid for ISTA Pharmaceuticals, the company said.

December 15, 2011

Short bursts of exercise appear to lower blood sugar in people with Type 2 diabetes, Canadian researchers have found.

December 13, 2011

The Federal Trade Commission has voted to approve Valeant's acquisitions of Dermik, a unit of French drug maker Sanofi that makes drugs for skin conditions, and Ortho Dermatologics, a division of Johnson & Johnson that also makes skin drugs.

November 21, 2011

Canadian drug maker Valeant Pharmaceuticals International is acquiring an Australian drug maker for up to A$700 million, Valeant said.

November 15, 2011

Family Dollar is expanding into California for the first time with the opening of four new stores in Ontario, Rialto, Riverside and Fontana.

November 7, 2011

Sentinel Capital Partners has acquired Sarasota, Fla.-based WellSpring Pharmaceutical, the private equity firm said Monday.

October 11, 2011

The retirement of Katz Group Canada CEO Andy Giancamilli come February will mark the rise of pharmacy veteran Frank Scorpiniti, who will take the helm of the Canadian retailer.


October 7, 2011

The news that Shoppers Drug Mart has appointed former McKesson Canada executive Domenic Pilla as its new president and CEO not only is significant news in its own right, but also is important as Pilla will inherit a chain that is wrestling with the impact of drug reforms in several provinces and faces its share of competitive challenges.

September 1, 2011

Proton-pump inhibitors may aggravate, not soothe, stomach discomfort created through chronic use of nonsteroidal anti-inflammatory drugs for such conditions as arthritis, according to research released Thursday.

August 19, 2011

Canada-based drug store chain Loblaw has extended its Get Checked Now diabetes program, the company announced Thursday.

July 20, 2011

Canadian drug maker Valeant Pharmaceuticals International has signed an agreement with Sanofi’s subsidiary in Canada to distribute a topical medication for osteoarthritis in the country.

July 19, 2011

PepsiCo's Canada operations has introduced its first soft drink bottle made from 100% recycled PET plastic.

July 13, 2011

PepsiCo Beverages Canada has introduced the 7UP EcoGreen bottle, Canada's — and North America's — first soft drink bottle made from 100% recycled polyethylene terephthalate, or PET, plastic, the company reported Wednesday.

June 30, 2011

Canadian drug maker Valeant Pharmaceuticals International will acquire rights to topical drugs for eczema and cold sores from Swedish drug maker Meda.

June 27, 2011

Walmart Canada has agreed to assume leasehold interests from Target Canada in up to 39 sites that currently are operated by Zellers.

June 8, 2011

Target’s board has finalized the decision to locate the company’s Canadian headquarters in Mississauga, Ontario, said president, chairman and CEO Gregg Steinhafel at a shareholders meeting in Pittsburgh on Wednesday.

May 31, 2011

Target has unveiled the first wave of the Zellers sites it will be taking over in Canada, representing 105 locations in all 10 Canadian provinces.

April 22, 2011

Valeant Pharmaceuticals International is taking its case directly to Cephalon’s shareholders in its effort to acquire the Frazer, Pa.-based drug maker.

March 30, 2011

GNC is ready to pull the trigger on a long-anticipated initial public offering this Friday, according to several published reports.

March 30, 2011

Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.

March 22, 2011

J. Michael Pearson has been appointed to chairman of the board at Valeant Pharmaceuticals, the drug maker said Tuesday.